ArticleEndocrinology, diabetes & metabolism case reports2020

Pembrolizumab-induced fulminant type 1 diabetes with C-peptide persistence at first referral.

Kazuhisa Kusuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.